CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - Management
What assessment and treatment are required prior to inserting the levonorgestrel-releasing intrauterine system (IUS)?
- Enquire about the user's preferences and any concerns about using the levonorgestrel intrauterine system (IUS).
- In young women and women with special needs, assess their competence to decide, and support them in making their own decisions about contraception.
- Exclude pregnancy.
- Check the UK Medical Eligibility Criteria to ensure that the woman is eligible for insertion of the levonorgestrel IUS.
- Assess the risk for sexually transmitted infection and, when appropriate, advise testing, promote safer sex, and/or refer for counselling (also consider each time the IUS is reinserted). If testing for sexually transmitted infections is requested, do this before inserting the device.
In depth
© NHS Institute for Innovation and Improvement